The Evolution of Skin Diagnostics As we advance into 2026, the landscape of dermatological diagnostics has undergone a remarkable transformation. Driven by technological innovations and a deeper ...

Psoriasis may not have a cure, but new research has found that significant relief could be achieved at the dinner table. In a clinical trial, scientists found that a Mediterranean diet could ...

Over 60 million people worldwide are affected by psoriasis, a chronic inflammatory skin disorder that causes red, scaly patches and persistent itching. A new study has found that following a ...

Please provide your email address to receive an email when new articles are posted on . The FDA expanded the indication for Tremfya (guselkumab) to children with plaque psoriasis or active psoriatic ...

The use of dupilumab for the treatment of atopic dermatitis was associated with an increased risk of psoriasis compared with other systemic agents. The association between dupilumab and psoriasis was ...

Tremfya is the first IL-23 inhibitor approved for pediatric plaque psoriasis and psoriatic arthritis, based on the PROTOSTAR trial's positive results. The PROTOSTAR trial demonstrated significant skin ...

In the Mediterranean diet group, 47.4% achieved a 75% reduction in PASI compared with 0% in the control group. HealthDay News — A 16-week Mediterranean diet intervention significantly improves ...

Very few studies have examined the relationship between psoriasis and addiction. But the results we do have show a possible link. One survey carried out by researchers in Germany looked at people ...

Bristol Myers Squibb Co. will sell its pill for psoriasis directly to cash-paying patients at a more than 80% discount to the drug’s list price, following President Donald Trump’s demand that ...

As psoriasis progresses or becomes more severe, though, topical treatments may not be enough to ease your symptoms. If that’s the case, your doctor may prescribe systemic treatments to calm the source ...

Experts at the Skin of Color Update highlighted the potential benefits of GLP-1 RAs in managing obesity, as well as psoriasis and hidradenitis suppurativa symptom management. The panel, “Addressing ...